2023

90 Publikationen
Gesamt Impact Faktor: 802.892

• Khalaveh F, Steiner I, Reinprecht A, Czech T, Kasprian G, Rössler K, Dorfer C.: Individualized surgical treatment of Chiari 1 malformation: A single-center experience. Clin Neurol Neurosurg. 2023 Jul; 230:107803. doi: 10.1016/j.clineuro.2023.107803. Epub 2023 May 24. IF: 1.9
• Gadenstaetter AJ, Auinger AB, Gerlitz M, Riss D, Dahm V, Yildiz E, Roessler K, Matula C, Arnoldner C.: Functional Outcome After Simultaneous Vestibular Schwannoma Resection and Cochlear Implantation With Intraoperative Cochlear Nerve Monitoring. Otolaryngol Head Neck Surg. 2023 Jun; 168(6):1502-1510. doi: 10.1002/ohn.233. Epub 2023 Jan 26. IF: 3.4
• Wolff L, Steindl A, Popov P, Dieckmann K, Gatterbauer B, Widhalm G, Berghoff AS,Preusser M, Raderer M, Kiesewetter B.: Clinical characteristics, treatment, and long-termoutcome of patients with brain metastases from thyroid cancer. Clin Exp Metastasis. 2023 Jun; 40(3):217-226. doi: 10.1007/s10585-023-10208-8. Epub 2023 May 23. IF: 4
• Madlener S, Furtner J, Stepien N, Senfter D, Mayr L, Zeyda M, Gramss L, Aistleitner B, Spiegl-Kreinecker S, Rivelles E, Dorfer C, Rössler K, Czech T, Azizi AA, Peyrl A, Lötsch-Gojo D, Müllauer L, Haberler C, Slavc I, Gojo J.: Clinical applicability of miR517a detection in liquid biopsies of ETMR patients. ActaNeuropathol. 2023 Jun; 145(6):843-846. doi: 10.1007/s00401-023-02567-z. Epub 2023 Apr 5. IF: 12.7
• Herta J, Loidl TB, Schmied T, Tomschik M, Khalaveh F, Wang WT, Dorfer C.: Retrospective comparison of percutaneous balloon compression and radiofrequency-thermocoagulation in the management of trigeminal neuralgia. Acta Neurochir (Wien) 2023 Jun 7. doi: 10.1007/s00701-023-05656-w. Online ahead of print .IF: 2.4
• Hoffmann L, Coras R, Kobow K, López-Rivera JA, Lal D, Leu C, Najm I, Nürnberg P, Herms J, Harter PN, Bien CG, Kalbhenn T, Müller M, Pieper T, Hartlieb T, Kudernatsch M, Hamer H, Brandner S, Rössler K, Blümcke I, Jabari S.: Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes. Acta Neuropathol. 2023 Jun; 145(6):815-827. doi: 10.1007/s00401-023-02561-5. Epub 2023 Mar 27. IF: 12.7
• Horvath LC, Bergmann F, Hosmann A, Greisenegger S, Kammerer K, Jilma B, Siller-Matula JM, Zeitlinger M, Gelbenegger G & Jorda A.: Endovascular thrombectomy with or without intravenous thrombolysis in large-vessel ischemic stroke: A non-inferiority meta-analysis of 6 randomised controlled trials. Vascular Pharmacology 2023 Jun;150:107177. doi: 10.1016/j.vph.2023.107177. Epub 2023 Apr 26. IF:4
• Weidinger A, Milivojev N, Hosmann A, Duvigneau JC, Szabo C, Törö G, Rauter L, Vaglio-Garro A, Mkrtchyan GV, TrofimovaL, Sharipov RR, Surin AM, Krasilnikova I.A., Pinelis VG, Tretter L, Moldzio R, Bayir H, Kagan VE, Bunikg VI, Kozlov, AV.: Oxoglutarate dehydrogenase complex controls glutamate-mediated neuronal death. Redox Biolog y2023 Jun; 62:102669, doi: 10.1016/j.redox.2023.102669. Epub 2023 Mar 11. IF: 11.4
• Tomschik M, Wiedner D, Herta J, Wais J, Winter F, Roessler K, Dorfer C.: The effect of perioperative non-steroidal anti-inflammatory drugs and male sex on the recurrence rates after chronic subdural hematoma evacuation. J Neurosurg Sci. 2023 Jun; 67(3):344-350. doi: 10.23736/S0390-5616.21.05216-4. Epub 2021 Mar 11. IF: 1.9
• Dahm V, Schwarz-Nemec U, Arnoldner MA, Liepins R, Auinger AB, Matula C, Arnoldner C.: MRI surveillance after translabyrinthine vestibular schwannoma resection and cochlear implantation: is it feasible? Eur Arch Otorhinolaryngol. 2023 Jun 2. doi: 10.1007/s00405-023-08036-3. Online ahead of print. IF: 2.6
• Hangel G, Schmitz-Abecassis B, Sollmann N, Pinto J, Arzanforoosh F, Barkhof F, Booth T, Calvo-Imirizaldu M, Cassia G, Chmelik M, Clement P, Ercan E, Fernández-Seara MA, Furtner J, Fuster-Garcia E, Grech-Sollars M, Guven NT, Hatay GH, Karami G, Keil VC, Kim M, Koekkoek JAF, Kukran S, Mancini L, Nechifor RE, Özcan A, Ozturk-Isik E, Piskin S, Schmainda KM, Svensson SF, Tseng CH, Unnikrishnan S, Vos F, Warnert E, Zhao MY, Jancalek R, Nunes T, Hirschler L, Smits M, Petr J, Emblem KE.: Advanced MR Techniques for Preoperative Glioma Characterization: Part 2. J Magn Reson Imaging. 2023 Jun; 57(6):1676-1695. doi: 10.1002/jmri.28663. Epub 2023 Mar 13.Review. IF: 5.119
• Hirschler L, Sollmann N, Schmitz-Abecassis B, Pinto J, Arzanforoosh F, Barkhof F, Booth T, Calvo-Imirizaldu M, Cassia G, Chmelik M, Clement P, Ercan E, Fernández-Seara MA, Furtner J, Fuster-Garcia E, Grech-Sollars M, Guven NT, Hatay GH, Karami G, Keil VC, Kim M, Koekkoek JAF, Kukran S, Mancini L, Nechifor RE, Özcan A, Ozturk-Isik E, Piskin S, Schmainda K, Svensson SF, Tseng CH, Unnikrishnan S, Vos F, Warnert E, Zhao MY, Jancalek R, Nunes T, Emblem KE, Smits M, Petr J, Hangel G.: Advanced MR Techniques for Preoperative Glioma Characterization: Part 1. J MagnReson Imaging. 2023 Jun; 57(6):1655-1675. doi: 10.1002/jmri.28662. Epub 2023 Mar 3.Review. IF: 5.119
• Niess F, Hingerl L, Strasser B, Bednarik P, Goranovic D, Niess E, Hangel G, Krššák M, Spurny-Dworak B, Scherer T, Lanzenberger R, Bogner W.: Noninvasive 3-Dimensional 1 H-Magnetic Resonance Spectroscopic Imaging of Human Brain Glucose and Neurotransmitter Metabolism Using Deuterium Labeling at 3T : Feasibility and Interscanner Reproducibility.Invest Radiol. 2023 Jun 1; 58(6):431-437. doi: 10.1097/RLI.0000000000000953. Epub 2023 Feb 4. IF: 10.065
• Micko ASG, Cho A, Heck S, Marik W, Wolfsberger S.: Does High-definition 3D Imaging Improve Orientation During Endoscopic Transsphenoidal Surgery? A Prospective Trial. OperNeurosurg (Hagerstown). 2023 May 1; 24(5):e330-e335. doi: 10.1227/ons.0000000000000581, Epub 2022 Dec 23. IF: 2.817
• Hosmann A, Jaber M, Roetzer-Pejrimovsky T, Timelthaler G, Borkovec M, Kiesel B, Wadiura LI, Millesi M, Mercea PA, Phillips J, Hervey-Jumper S, Berghoff AS, Hainfellner JA, Berger Mitchel S, Stummer W, Widhalm G.: CD34 microvascularity in low-grade glioma: correlation with 5-aminolevulinic acid fluorescence and patient prognosis in a multicenter study at three specialized centers. Journal of Neurosurgery 1: 1–10. 2022 Sep 16; 138(5):1281-1290. doi: 10.3171/2022.7.JNS22921. Print 2023 May 1. IF: 5.526
• Sturtzel C, Grissenberger S, Bozatzi P, Scheuringer E, Wenninger-Weinzierl A, Zajec Z, Dernovšek J, Pascoal S, Gehl V, Kutsch A, Granig A, Rifatbegovic F, Carre M, Lang A,Valtingojer I, Moll J, Lötsch D, Erhart F, Widhalm G, Surdez D, Delattre O, André N,Stampfl J, Tomašič T, Taschner-Mandl S, Distel M.: Refined high-content imaging-basedphenotypic drug screening in zebrafish xenografts. NPJ Precis Oncol. 2023 May18; 7(1):44. doi: 10.1038/s41698-023-00386-9.  IF: 10.123
• Bsteh G, Macher S, Krajnc N, Pruckner P, Marik W, Mitsch C, Novak K, Pemp B, Wöber C.: Idiopathic intracranial hypertension presenting with migraine phenotype is associated with unfavorable headache outcomes. Headache. 2023 May; 63(5):601-610. doi: 10.1111/head.14478. Epub 2023 Feb 8. IF: 5.311
• Hollon TC, Golfinos JG, Orringer DA, Berger M, Hervey-Jumper SL, Muraszko KM, Freudiger C, Heth J, Sagher O, Jiang C, Chowdury A, Moin MN, Kondepudi A, Aabedi AA, Adapa AR, Al-Holou W, Wadiura L, Widhalm G, Neuschmelting V, Reinecke D, Camelo-Piragua S.:102 AI-Based Molecular Classification of Diffuse Gliomas using Rapid, Label-Free Optical Imaging. Neurosurgery. 2023 Apr 1; 69(Suppl 1):22-23. doi: 10.1227/neu.0000000000002375_102.  IF: 5.315
• Tomasich E, Steindl A, Paiato C, Hatziioannou T, Kleinberger M, Berchtold L, Puhr R, Hainfellner JA, Müllauer L, Widhalm G, Eckert F, Bartsch R, Heller G, Preusser M, Berghoff AS.: Frequent overexpression of HER3 in brain metastases from breast and lungcancer. Clin Cancer Res. 2023 Apr 10; CCR-23-0020. doi: 10.1158/1078-0432.CCR-23-0020. Epub ahead of print. IF: 13.801
• Hollon T, Jiang C, Chowdury A, Nasir-Moin M, Kondepudi A, Aabedi A, Adapa A, Al-Holou W, Heth J, Sagher O, Lowenstein P, Castro M, Wadiura LI, Widhalm G, Neuschmelting V, Reinecke D, von Spreckelsen N, Berger MS, Hervey-Jumper SL,Golfinos JG, Snuderl M, Camelo-Piragua S, Freudiger C, Lee H, Orringer DA.: Artificial -intelligence-based molecular classification of diffuse gliomas using rapid, label-free optical imaging. Nat Med. 2023 Apr; 29(4):828-832. doi: 10.1038/s41591-023-02252-4. Epub2023 Mar 23. IF: 87.244
• López-Rivera JA, Leu C, Macnee M, Khoury J, Hoffmann L, Coras R, Kobow K, Bhattarai N, Pérez-Palma E, Hamer H, Brandner S, Rössler K, Bien CG, Kalbhenn T, Pieper T, Hartlieb T, Butler E, Genovese G, Becker K, Altmüller J, Niestroj LM, Ferguson L, Busch RM, Nürnberg P, Najm I, Blümcke I, Lal D.: The genomic landscape across 474 surgically accessible epileptogenic human brain lesions. Brain. 2023 Apr 19; 146(4):1342-1356. doi: 10.1093/brain/awac376. IF: 15.255
• Bergen ES, Friedrich A, Scherleitner P, Ferreira P, Kiesel B, Widhalm G, Kiesewetter B, Eckert F, Prager GW, Preusser M, Berghoff AS. Brain metastases fromhepatopancreatobiliary malignancies. ClinExp Metastasis. 2023 Apr; 40(2):177-185. doi:10.1007/s10585-023-10201-1. Epub 2023 Mar 22. IF: 4.510
• Stepien N, Senfter D, Furtner J, Haberler C, Dorfer C, Czech T, Lötsch-Gojo D, Mayr L, Hedrich C, Baumgartner A, Aliotti-Lippolis M, Schned H, Holler J, Bruckner K, Slavc I, Azizi AA, Peyrl A, Müllauer L, Madlener S, Gojo J.: Proof-of-Concept for Liquid Biopsy Disease Monitoring of MYC-Amplified Group 3 Medulloblastoma by Droplet Digital PCR. Cancers (Basel). 2023 Apr 28; 15(9):2525. doi: 10.3390/cancers15092525. IF: 6.575
• Bednarik P, Goranovic D, Svatkova A, Niess F, Hingerl L, Strasser B, Deelchand DK, Spurny-Dworak B, Krssak M, Trattnig S, Hangel G, Scherer T, Lanzenberger R, Bogner W.: 1H magnetic resonance spectroscopic imaging of deuterated glucose and of neurotransmitter metabolism at7 T in the human brain. Nat Biomed Eng. 2023 Apr 27. doi: 10.1038/s41551-023-01035-z. Online ahead of print. IF:29.234
• Niess F, Strasser B, Hingerl L, Niess E, Motyka S, Hangel G, Krššák M, Gruber S, Spurny-Dworak B, Trattnig S, Scherer T, Lanzenberger R, Bogner W.: Reproducibility of 3D MRSI for imaging human brain glucose metabolism using direct (2 H) and indirect (1 H) detection of deuterium labeled compounds at 7T and clinical 3T. medRxiv. 2023 Apr 17:2023.04.17.23288672. doi: 10.1101/2023.04.17.23288672. IF: 4.7
• Pruckner P, Nenning KH, Fischmeister FPS, Yildirim MS, Schwarz M, Reitner A, Aull-Watschinger S, Koren J, Baumgartner C, Prayer D, Rössler K, Dorfer C, Czech T, Pataraia E, Kasprian G, Bonelli S.: Visual outcomes after anterior temporal lobectomy and transsylvian selective amygdalohippocampectomy: A quantitative comparison of clinical and diffusion data. Epilepsia. 2023 Mar; 64(3):705-717. doi: 10.1111/epi.17490. Epub 2023 Jan 12. IF: 6.74
• Taubenschmid-Stowers J, Orthofer M, Laemmerer A, Krauditsch C, Rózsová M, Studer C, Lötsch D, Gojo J, Gabler L, Dyczynski M, Efferth T, Hagelkruys A, Widhalm G, Peyrl A, Spiegl-Kreinecker S, Hoepfner D, Bian S, Berger W, Knoblich JA, Elling U, Horn M, Penninger JM. A whole-genome scan for Artemisinin cytotoxicity reveals a novel therapy for human brain tumors. EMBO Mol Med. 2023 Mar 8; 15(3):e16959. doi: 10.15252/emmm.202216959. Epub 2023 Feb 6. IF: 14.005
• Maslarova A, Zhao Y, Rösch J, Dörfler A, Coras R, Blümcke I, Lang J, Schmidt M, Hamer HM, Reindl C, Welte TM, Rampp S, Rössler K, Buchfelder M, Brandner S.: Surgical planning, histopathology findings and postoperative outcome in MR-negative extra-temporal epilepsy using intracranial EEG, functional imaging, magnetoencephalography, neuronavigation and intraoperative MRI. Clin Neurol Neurosurg. 2023 Mar; 226:107603. doi: 10.1016/j.clineuro.2023.107603. Epub 2023 Jan 18. IF: 1.885
• Dodier P, Kranawetter B, Hirschmann D, Dogan M, Cho A, Untersteiner H, Göbl P, Gatterbauer B, Wang WT, Dorfer C, Rössler K, Bavinzski G, Frischer JM.: Outcome of 107 conservatively managed unruptured brain arteriovenous malformations: a single center's 30-year experience. J Neurosurg. 2023 Mar 24:1-11. doi: 10.3171/2023.2.JNS222675. Online ahead of print. IF: 5.526
• Hedrich C, Gojo J, Azizi A, Peyrl A, Slavc I, Winter F, Czech T, Dorfer C.: Placement of EVD in pediatric posterior fossa tumors: safe and efficient or old-fashioned? The Vienna experience. Childs Nerv Syst 2023 Mar 23. doi: 10.1007/s00381-023-05917-0. Online ahead of print. IF: 1.532
• Goel K, Pek V, Shlobin NA, Chen JS, Wang A, Ibrahim GM, Hadjinicolaou A, Roessler K, Dudley RW, Nguyen DK, El-Tahry R, Fallah A, Weil AG.: Clinical utility of intraoperative electrocorticography for epilepsy surgery: A systematic review and meta-analysis. Epilepsia. 2023 Feb; 64(2):253-265. doi: 10.1111/epi.17472. Epub 2022 Dec 12. IF: 6.74
• Reichert D, Wadiura LI, Erkkilae MT, Gesperger J, Lang A, Roetzer-Pejrimovsky T, Makolli J, Woehrer A, Wilzbach M, Hauger C, Kiesel B, Andreana M, Unterhuber A, Drexler W, Widhalm G, Leitgeb RA.: Flavin fluorescence lifetime and autofluorescence optical redox ratio for improved visualization and classification of brain tumors. FrontOncol. 2023 Feb 20; 13:1105648. doi: 10.3389/fonc.2023.1105648. eCollection 2023. IF: 5.738
• Papp L, Rasul S, Spielvogel CP, Krajnc D, Poetsch N, Woehrer A, Patronas EM, Ecsedi B, Furtner J, Mitterhauser M, Rausch I, Widhalm G, Beyer T, Hacker M, Traub-Weidinger T.: Sex-specific radiomic features of L-[S-methyl-11C] methionine PET in patients with newly-diagnosed gliomas in relation to IDH1 predictability. Front Oncol. 2023 Feb 3; 13:986788. doi: 10.3389/fonc.2023.986788. IF: 5.738
• Tomschik M, Renaud E, Jäger F, Paternostro C, Rath J, Rinner W, Zulehner G, Zimprich F, Cetin H.: The diagnostic and prognostic utility of repetitive nerve stimulation in patients with myasthenia gravis. Sci Rep 2023 Feb 20;13(1):2985. doi: 10.1038/s41598-023-30154-5. IF: 4.997
• Lipka A, Niess E, Dal-Bianco A, Hangel GJ, Rommer PS, Strasser B, Motyka S, Hingerl L, Berger T, Hnilicová P, Kantorová E, Leutmezer F, Kurča E, Gruber S, Trattnig S, Bogner W.: Lesion-Specific Metabolic Alterations in Relapsing-Remitting Multiple Sclerosis Via 7 T Magnetic Resonance Spectroscopic Imaging. Invest Radiol. 2023 Feb 1; 58(2):156-165. doi: 10.1097/RLI.0000000000000913. Epub 2022 Aug 28. IF: 10.065
• Milchram L, Kulovics R, Sonntagbauer M, Schönthaler S, Vierlinger K, Dorfer C, Cameron C, Saydam O, Weinhäusel A.: Antibody Profiling and In Silico Functional Analysis of Differentially Reactive Antibody Signatures of Glioblastomas and Meningiomas. Int J Mol Sci. 2023 Jan 11;24(2):1411. doi: 10.3390/ijms24021411. IF: 6.208
• Hoffmann-Lamplmair D, Gram A, Krottendorfer K, Peyrl A, Leiss U, Czech T, Slavc I, Pletschko T.: Sociocultural variables have a major impact on participation in patients treated for paediatric posterior fossa tumours. Child Care Health Dev. 2023 Jan; 49(1):106-118. doi: 10.1111/cch.13023. Epub 2022 Jun 22. IF: 2.943
• Roeder SS, Bonnin EA, Wu TD, Guerquin-Kern JL, Jabari S, Brandner S, Eyüpoglu IY, Gollwitzer S, Hamer HM, Gerner ST, Doeppner TR, Rummel C, Englund E, Heimke-Brinck R, Borst T, Daniel C, Amann K, Schlötzer-Schrehardt U, Tonchev AB, Roessler K, Schwab S, Bergmann O, Rizzoli SO, Huttner HB.: Tracking cell turnover in human brain using 15N-thymidine imaging mass spectrometry. Front Neurosci. 2023 Oct 5; 17:1274607. doi: 10.3389/fnins.2023.1274607. IF: 3.2
• Khalaveh F, Zeiser V, Cho A, Schmelzer S, Reinprecht A, Herta J, Roessler K, Dorfer C.: Predicting the need for cerebrospinal fluid shunt implantation after spontaneous intracerebral hemorrhage: a challenging task. Front Neurol. 2023 Dec 7; 14:1255477. doi: 10.3389/fneur.2023.1255477. IF: 2.7
• Winter F, Hasslinger S, Frueh A, Marik W, Raudner M, Hirschmann D, Kuess M, Salzmann SN, Rienmueller A, Roessler K, Dorfer C, Herta J.: Incidence, risk factors, and treatment of incidental durotomy during decompression in degenerative lumbar spine conditions. J Neurosurg Sci. 2023 Aug; 67(4):507-511. doi: 10.23736/S0390-5616.21.05404-7. Epub 2021 Nov 11. IF: 1.3
• Tomschik M, Herta J, Wais J, Winter F, Hangel G, Kasprian G, Feucht M, Dorfer C, Roessler K.:Technical Note: Advantages of a 2-Room Intraoperative 3-Tesla Magnetic Resonance Imaging Operating Suite for Performing Laser Interstitial Thermal Therapy in Pediatric Epilepsy and Tumor Surgery. World Neurosurg. 2023 Nov; 179:146-152. doi: 10.1016/j.wneu.2023.08.089. Epub 2023 Aug 25. IF: 1.9
• Honke J, Hoffmann L, Coras R, Kobow K, Leu C, Pieper T, Hartlieb T, Bien CG, Woermann F, Cloppenborg T, Kalbhenn T, Gaballa A, Hamer H, Brandner S, Rössler K, Dörfler A, Rampp S, Lemke JR, Baldassari S, Baulac S, Lal D, Nürnberg P, Blümcke I.: Deep histopathology genotype-phenotype analysis of focal cortical dysplasia type II differentiates between the GATOR1-altered autophagocytic subtype IIa and MTOR-altered migration deficient subtype IIb. Acta Neuropathol Commun. 2023 Nov 9; 11(1):179. doi: 10.1186/s40478-023-01675-x. IF: 6.2
• Ciobanu-Caraus O, Czech T, Peyrl A, Haberler C, Kasprian G, Furtner J, Kool M, Sill M, Frischer JM, Cho A, Slavc I, Rössler K, Gojo J, Dorfer C.: The Site of Origin of Medulloblastoma: Surgical Observations Correlated to Molecular Groups. Cancers (Basel). 2023 Oct 7; 15(19):4877. doi: 10.3390/cancers15194877. IF: 4.5
• Reindl C, Walther K, Allgäuer AL, Lang JD, Welte TM, Stritzelberger J, Gollwitzer S, Schwarz M, Trollmann R, Madzar D, Knott M, Doerfler A, Seifert F, Rössler K, Brandner S, Rampp S, Schwab S, Hamer HM.: Age of epilepsy on set as modulating factor for naming deficit after epilepsy surgery: a voxel-based lesion-symptom mapping study. Sci Rep. 2023 Sep 1; 13(1):14395. doi: 10.1038/s41598-023-40722-4. IF: 3.8
• Lang A, Jeron RL, Lontzek B, Kiesel B, Mischkulnig M, Berghoff AS, Ricken G, Wöhrer A, Rössler K, Lötsch-Gojo D, Roetzer-Pejrimovsky T, Berger W, Hainfellner JA, Höftberger R, Widhalm G, Erhart F.: Mapping high-grade glioma immune infiltration to 5-ALA fluorescence levels: TCGA data computation, classical histology, and digital image analysis. J Neurooncol. 2023 Aug; 164(1):211-220. doi: 10.1007/s11060-023-04406-3. Epub 2023 Aug 6. IF: 3.2
• Hoffmann L, Coras R, Kobow K, López-Rivera JA, Lal D, Leu C, Najm I, Nürnberg P, Herms J, Harter PN, Bien CG, Kalbhenn T, Müller M, Pieper T, Hartlieb T, Kudernatsch M, Hamer H, Brandner S, Rössler K, Blümcke I, Jabari S.: Correction to: Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes. Acta Neuropathol. 2023 Jun; 145(6):851-855. doi: 10.1007/s00401-023-02577-x. Erratum for: Acta Neuropathol. 2023 Jun; 145(6):815-827. doi: 10.1007/s00401-023-02561-5. IF: 12.7
• Khalaveh F, Cho A, Shaltout A, Untersteiner H, Kranawetter B, Hirschmann D, Göbl P, Marik W, Gatterbauer B, Rössler K, Dorfer C, Frischer JM.: Concomitant radiosurgical and targeted oncological treatment improves the outcome of patients with brain metastases from gastrointestinal cancer. RadiatOncol. 2023 Dec 9; 18(1):197. doi: 10.1186/s13014-023-02383-5. IF: 3.3
• Miebach L, Melo-Zainzinger G, Freund E, Clemen R, Cecchini AL, Bekeschus S.: Medical Gas Plasma Technology Combines with Antimelanoma Therapies and Promotes Immune-Checkpoint Therapy Responses. Adv Sci (Weinh). 2023 Oct; 10(28):e2303183. doi: 10.1002/advs.202303183. Epub 2023 Aug 4. IF: 14.3
• Pemberton HG, Wu J, Kommers I, Müller DMJ, Hu Y, Goodkin O, Vos SB, Bisdas S, Robe PA, Ardon H, Bello L, Rossi M, Sciortino T, Nibali MC, Berger MS, Hervey-Jumper SL, Bouwknegt W, Van den Brink WA, Furtner J, Han SJ, Idema AJS, Kiesel B, Widhalm G, Kloet A, Wagemakers M, Zwinderman AH, Krieg SM, Mandonnet E, Prados F, de Witt Hamer P, Barkhof F, Eijgelaar RS.: Multi-class glioma segmentation on real-world data with missing MRI sequences: comparison of three deep learning algorithms. Sci Rep. 2023 Nov 2; 13(1):18911. doi: 10.1038/s41598-023-44794-0. IF: 3.8
• Helland RH, Ferles A, Pedersen A, Kommers I, Ardon H, Barkhof F, Bello L, Berger MS, Dunås T, Nibali MC, Furtner J, Hervey-Jumper S, Idema AJS, Kiesel B, Tewari RN, Mandonnet E, Müller DMJ, Robe PA, Rossi M, Sagberg LM, Sciortino T, Aalders T, Wagemakers M, Widhalm G, Witte MG, Zwinderman AH, Majewska PL, Jakola AS, Solheim O, Hamer PCW, Reinertsen I, Eijgelaar RS, Bouget D.: Segmentation of glioblastomas in early post-operative multi-modal MRI with deep neural networks. Sci Rep. 2023 Nov 2; 13(1):18897. doi: 10.1038/s41598-023-45456-x. IF: 3.8
• Mischkulnig M, Traxler D, Wadiura LI, Lang A, Millesi M, Kiesel B, Widhalm G.: Comparison of minimal detectable protoporphyrin IX concentrations with a loupe device and conventional 5-ALA fluorescence microscopy: an experimental study. J Biomed Opt. 2023 Oct; 28(10):106004. doi: 10.1117/1.JBO.28.10.106004. Epub 2023 Oct 31. IF: 3
• Pruckner P, Mitsch C, Macher S, Krajnc N, Marik W, Novak K, Wöber C, Pemp B, Bsteh G.: The Vienna idiopathic intracranial hypertension database-An Austrian registry. Wien KlinWochenschr. 2024 Jan; 136(1-2):32-39. doi: 10.1007/s00508-023-02252-x. Epub 2023 Aug 31. IF: 1.9
• Bsteh G, Marik W, Krajnc N, Macher S, Mitsch C, Pruckner P, Novak K, Wöber C, Pemp B.: MRI features of idiopathic intracranial hypertension are not prognostic of visual and headache outcome. J HeadachePain. 2023 Jul 28; 24(1):97. doi: 10.1186/s10194-023-01641-x. IF: 7.4
• Bsteh G, Marik W, Macher S, Schmidbauer V, Krajnc N, Pruckner P, Mitsch C, Novak K, Wöber C, Pemp B.: Impact of rater experience and referral question on detecting magnetic resonance imaging features of idiopathic intracranial hypertension. Eur J Neurol. 2023 Oct; 30(10):3314-3321. doi: 10.1111/ene.15986. Epub 2023 Jul 27. IF: 4.5
• Gundacker A, Glat M, Wais J, Stoehrmann P, Pollak A, Pollak DD.: Early-life iron deficiency persistently disrupts affective behaviour in mice. Ann Med. 2023 Dec; 55(1):1265-1277. doi: 10.1080/07853890.2023.2191003. IF: 4.9
• Marik W, Cardoso PL, Springer E, Bogner W, Preusser M, Widhalm G, Hangel G, Hainfellner JA, Rausch I, Weber M, Schmidbauer V, Traub-Weidinger T, Trattnig S.: Evaluation of Gliomas with Magnetic Resonance Fingerprinting with PET Correlation-A Comparative Study. Cancers (Basel). 2023 May 12; 15(10):2740. doi: 10.3390/cancers15102740. IF: 4.5
• Herta J, Cho A, Roetzer-Pejrimovsky T, Höftberger R, Marik W, Kronreif G, Peilnsteiner T, Rössler K, Wolfsberger S.: Optimizing maximum resection of glioblastoma: Raman spectroscopy versus 5-aminolevulinic acid. J Neurosurg. 2022 Dec 23; 139(2):334-343. doi: 10.3171/2022.11.JNS22693. IF: 4.1
• Roth J, Weiner HL, Chandra PS, Machado HR, Blount JP, Dorfmüller G, Dorfer C, Panigrahi M, Uliel-Sibony S, Constantini S.: The Pediatric Epilepsy Surgery Interest Group (PESIG) under the auspice of the ISPN Research Committee: Availability of relevant technology and geographical distribution. Childs Nerv Syst. 2024 Apr; 40(4):1239-1244. doi: 10.1007/s00381-023-06236-0. Epub 2023 Nov 30. IF: 1
• Halbritter F, Farlik M, Schwentner R, Jug G, Fortelny N, Schnöller T, Pisa H, Schuster LC, Reinprecht A, Czech T, Gojo J, Holter W, Minkov M, Bauer WM, Simonitsch-Klupp I, Bock C, Hutter C.: Epigenomics and Single-Cell Sequencing Define a Developmental Hierarchy in Langerhans Cell Histiocytosis. Cancer Discov. 2019 Oct; 9(10):1406-1421. doi: 10.1158/2159-8290.CD-19-0138. Epub 2019 Jul 25. IF: 3.6
• Tucker DW, Pangal DJ, Du R, Gogia AS, Tafreshi A, Ruzevick J, Hurth KT, Triche T Jr, Micko A, Carpten JD, Shiroishi MS, Carmichael JD, Rhie SK, Zada G.: Validation of Myc-Associated Protein X (MAX) regulation in growth hormone secreting and nonfunctional pituitary adenoma. PLoS One. 2023 Apr 27; 18(4):e0284949. doi: 10.1371/journal.pone.0284949. IF: 3.7
• Mischkulnig M, Hopp B, Wadiura LI, Khalaveh F, Kiesel B, Rössler K, Widhalm G, Dorfer C.: Treatment of high-grade glioma patients during the COVID-19 pandemic: Impact on overall survival, tumor size and delay of treatment. PLoS One. 2023 Jun 30; 18(6):e0287993. doi: 10.1371/journal.pone.0287993. IF: 3.7
• Krajnc N, Itariu B, Macher S, Marik W, Harreiter J, Michl M, Novak K, Wöber C, Pemp B, Bsteh G.: Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension. J Headache Pain. 2023 Jul 18; 24(1):89. doi: 10.1186/s10194-023-01631-z. IF: 7.4
• Rössler, K., Dorfer, C.: New epilepsy surgical techniques and intraoperative monitoring in non-lesional MRI negative epilepsy. Clin Epileptol 2023; 36:132–138. doi: https://doi.org/10.1007/s10309-023-00569-1. Epub Mar 13. IF: n.V.
• Brandstetter, M., Mallouhi, A., & Alesch, F.: The foramen ovale: a keyhole to the brain? Computer simulations of percutaneous FO punctures. Egyptian Journal of Neurosurgery  2023; 38(1): 22. doi: https://doi.org/10.1186/s41984-023-00197-x. IF: 0.2
• Detomas M, Ritzel K, Nasi-Kordhishti I, Schernthaner-Reiter MH, Losa M, Tröger V, Altieri B, Kroiss M, Kickuth R, Fassnacht M, Micko A, Honegger J, Reincke M, Deutschbein T.: Bilateral inferior petrosal sinus sampling with human CRH stimulation in ACTH-dependent Cushing's syndrome: results from a retrospective multicenter study. Eur J Endocrinol. 2023 May 18; lvad050. doi: 10.1093/ejendo/lvad050. Epub ahead of print. IF: 5.8
• Kampf S, Micko A, Stojkovic S, Nackenhorst M, Demyanets S, Eilenberg WH, Krenn C, Wojta J, Neumayer C.: Elevated EMMPRIN Serum Levels Indicate Plaque Vulnerability in Patients With Asymptomatic High Grade Carotid Stenosis. Eur J Vasc Endovasc Surg. 2023 Apr; 65(4):474-483. doi: 10.1016/j.ejvs.2022.12.010. Epub 2022 Dec 15. IF: 5.7
• Lipka A, Bogner W, Dal-Bianco A, Hangel GJ, Rommer PS, Strasser B, Motyka S, Hingerl L, Berger T, Leutmezer F, Gruber S, Trattnig S, Niess E.: Metabolic Insights into Iron Deposition in Relapsing-Remitting Multiple Sclerosis via 7 T Magnetic Resonance Spectroscopic Imaging. Neuroimage Clin. 2023; 40:103524. doi: 10.1016/j.nicl.2023.103524. Epub 2023 Oct 14. IF: 4.2
• Hosmann A, Hari S, Misra BK.: Cystic recurrence of vestibular schwannoma post-radiosurgery: an institutional experience. Acta Neurochir (Wien). 2023 Dec; 165(12):4149-4156. doi: 10.1007/s00701-023-05841-x. Epub 2023 Nov 27. IF: 2.4
• Khalaveh F, Mischkulnig M, Zeiser V, Vossen MG, Reinprecht A, Dorfer C, Rössler K, Herta J.: Where to Draw Cerebrospinal Fluid from an External Ventricular Drain? Comparison of Cerebrospinal Fluid Parameters between Two Different Collection Sites. Diagnostics (Basel). 2023 Nov 27; 13(23):3543. doi: 10.3390/diagnostics13233543. IF: 3.6
• Nenning KH, Gesperger J, Furtner J, Nemc A, Roetzer-Pejrimovsky T, Choi SW, Mitter C, Leber SL, Hofmanninger J, Klughammer J, Ergüner B, Bauer M, Brada M, Chong K, Brandner-Kokalj T, Freyschlag CF, Grams A, Haybaeck J, Hoenigschnabl S, Hoffermann M, Iglseder S, Kiesel B, Kitzwoegerer M, Kleindienst W, Marhold F, Moser P, Oberndorfer S, Pinggera D, Scheichel F, Sherif C, Stockhammer G, Stultschnig M, Thomé C, Trenkler J, Urbanic-Purkart T, Weis S, Widhalm G, Wuertz F, Preusser M, Baumann B, Simonitsch-Klupp I, Nam DH, Bock C, Langs G, Woehrer A.: Radiomic features define risk and are linked to DNA methylation attributes in primary CNS lymphoma. Neurooncol Adv. 2023 Oct 18; 5(1):vdad136. doi: 10.1093/noajnl/vdad136. IF: 3.5
• Bruckner K, Madlener S, Biagi Junior CAO, Gabler L, Senfter D, Jeong D, Jiang L, Englinger B, Jaunecker C, Bilban M, Haberler C, Dorfer C, Rössler K, Kool M, Berger W, Filbin MG, Lötsch-Gojo D, Gojo J.: CHARACTERIZATION OF THE SPATIAL ARCHITECTURE OF INTRATUMORAL CELL STATES IN PEDIATRIC HIGH-RISK EPENDYMOMA. Neuro Oncol. 2023 Jun 12; 25(Suppl 1):i29. doi: 10.1093/neuonc/noad073.115. IF: 15.9
• Liu I, Alencastro Veiga Cruzeiro G, Bjerke L, Rogers RF, Grabovska Y, Beck A, Mackay A, Barron T, Hack OA, Quezada MA, Molinari V, Shaw ML, Perez-Somarriba M, Temelso S, Raynaud F, Ruddle R, Panditharatna E, Englinger B, Mire HM, Jiang L, Nascimento A, LaBelle J, Haase R, Rozowsky J, Neyazi S, Baumgartner AC, Castellani S, Hoffman SE, Cameron A, Morrow M, Nguyen QD, Pericoli G, Madlener S, Mayr L, Dorfer C, Geyeregger R, Rota C, Ricken G, Ligon KL, Alexandrescu S, Cartaxo RT, Lau B, Uphadhyaya S, Koschmann C, Braun E, Danan-Gotthold M, Hu L, Siletti K, Sundström E, Hodge R, Lein E, Agnihotri S, Eisenstat DD, Stapleton S, King A, Bleil C, Mastronuzzi A, Cole KA, Waanders AJ, Montero Carcaboso A, Schüller U, Hargrave D, Vinci M, Carceller F, Haberler C, Slavc I, Linnarsson S, Gojo J, Monje M, Jones C, Filbin MG.: Preturbing GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant. Cancer Cell. 2024 Aug; 27:S1535-6108(24)00305-2. doi: 10.1016/j.ccell.2024.08.006. Epub ahead of print. IF: 15.9
• Liu I, Jiang L, Samuelsson ER, Marco Salas S, Beck A, Hack OA, Jeong D, Shaw ML, Englinger B, LaBelle J, Mire HM, Madlener S, Mayr L, Quezada MA, Trissal M, Panditharatna E, Ernst KJ, Vogelzang J, Gatesman TA, Halbert ME, Palova H, Pokorna P, Sterba J, Slaby O, Geyeregger R, Diaz A, Findlay IJ, Dun MD, Resnick A, Suvà ML, Jones DTW, Agnihotri S, Svedlund J, Koschmann C, Haberler C, Czech T, Slavc I, Cotter JA, Ligon KL, Alexandrescu S, Yung WKA, Arrillaga-Romany I, Gojo J, Monje M, Nilsson M, Filbin MG.: The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location. Nat Genet. 2022 Dec; 54(12):1881-1894. doi: 10.1038/s41588-022-01236-3. Epub 2022 Dec 5. IF: 15.9
• Mayr L, Mager L, Gabler L, Madlener S, Berger J, Kirchhofer D, Lämmerer A, Bruckner K, Lötsch D, Berger W, Gojo J.: COMBINATORIAL ACTIVITY OF CDK4/6-INHIBITORS AND TRAMETINIB IN PEDIATRIC HIGH-GRADE GLIOMA WITH BRAFV600E MUTATION AND HOMOZYGOUS CDKN2A DELETION. Neuro-Oncology, 2023 Jun; 25, (Suppl 1):i40, doi:10.1093/neuonc/noad073.157. IF: 15.9
• Stepien N, Mayr L, Hedrich C, Lippolis MA, Schned H, Baumgartner A, Raimann A, Schmook MT, Traub-Weidinger T, Dorfer C, Hartmann G, Senfter D, Madlener S, Peyrl A, Azizi AA, Haberler C, Müllauer L, Gojo J.: EXPERIENCE WITH THE SELECTIVE FIBROBLAST GROWTH FACTOR INHIBITOR ERDAFITINIB IN THREE PEDIATRIC PATIENTS WITH CNS TUMORS. Neuro Oncol. 2023 Jun 12; 25(Suppl 1):i80–1. doi: 10.1093/neuonc/noad073.311. IF: 15.9
• Trissal M, Mayr L, Schwark K, LaBelle J, Kong S, Furtner J, Weiler-Wichtl L, Supko J, Rozowsky J, Hack O, Groves A, Marques J, Leiss U, Rosenmayr V, Dubois F, Greenwald NF, Madlener S, Guntner AS, Pálová H, Stepien N, Lötsch-Gojo D, Dorfer C, Dieckmann K, Peyrl A, Azizi AA, Baumgartner A, Slabý O, Pokorná P, Bandopadhayay P, Rameen_Beroukhim@dfci.harvard.edu Beroukhim RB, Ligon KL, Kramm CM, Bronsema A, Bailey S, Stucklin AG, Mueller SM, Jones DTW, Jäger N, Mullauer L, Haberler C, Kumar-Sinha C, Chinnaiyan A, Mody R, Sterba.Jaroslav@fnbrno.cz Štěrba JŠ, Skrypek M, Martinez N, Bowers DC, Koschmann CK, Gojo J, Filbin M.: CLINICAL RESPONSE TO THE PDGFRA/KIT INHIBITOR AVAPRITINIB IN PEDIATRIC AND YOUNG ADULT HIGH-GRADE GLIOMA PATIENTS WITH H3K27M OR PDGFRA GENOMIC ALTERATIONS. Neuro Oncol. 2023 Jun 12; 25(Suppl 1):i43–4. doi: 10.1093/neuonc/noad073.168.  IF: 15.9
• Beck A, Gabler L, Cruzeiro GAV, Lambo S, Englinger B, Shaw ML, Hack OA, Liu I, Junior CAODB, Haase RD, Klenner M, Freidel P, Madlener S, Mayr L, Senfter D, Peyrl A, Slavc I, Lötsch D, Dorfer C, Haberler C, Pfister SM, Baird L, Chi SN, Alexandrescu S, Gojo J, Kool M, Hovestadt V, Filbin MG.: SINGLE-CELL TRANSCRIPTOME ANALYSIS REVEALS CELLULAR HIERARCHIES AND THERAPEUTIC VULNERABILITIES OF ETMR. Neuro Oncol. 2023 Jun 12; 25(Suppl 1):i3. doi: 10.1093/neuonc/noad073.010.   IF: 15.9
• Mair M, Tomasich E, Paiato C, Widhalm G, Eckert F, Sahm F, Hainfellner J. A., Berghoff A. S, Preusser M.: Human epidermal growth factor receptor 2/3 (HER2/HER3) expression in higher-grade meningioma. Journal of Clinical Oncology. 2023; 41(Suppl 16): e14063-e14063:41. doi: 10.1200/JCO.2023.41.16_suppl.e14063. IF: 45.4
• Haberler C, Muller P, Müllauer L, Peyrl A, Czech T, Wimmer K, Slavc I.: DEFECTS OF MISMATCH REPAIR PROTEINS IN PEDIATRIC HIGH GRADE GLIOMAS. Neuro Oncol. 2020 Dec 4; 22(Suppl 3):iii351–2. doi: 10.1093/neuonc/noaa222.325. IF: 6.4
• Leibetseder, A. Mair M,Aichholzer M, Widhalm G, Eckert F, Wöhrer A, Weis S, Helbok R, Preusser M, Pichler J, Berghoff A.S.: Progression risk after pregnancy in patients with glioma. Annals of Oncology. 2023 Oct; 34(Suppl 2):S402 doi: 10.1016/j.annonc.2023.09.1722. IF: 50.5
• Steindl A, Kienzle A, Tomasich E, Berger J.M., Englisch C, Gottmann L, Korpan M, Kleinberger M, Starzer A.M., Kiesel B, Widhalm G, Eckert F, Preusser M, Berghoff A.S.: S100A9 serum levels are associated with survival prognosis in patients with brain metastases. Annals of Oncology. 2023 Oct; 34(Suppl 2):S405. doi: 10.1016/j.annonc.2023.09.1731. IF: 50.5
• Song Y, Miller-Michlits Y, Greutter L, Kiesel B, Loetsch-Gojo D, Redl V, Gesperger J, Breu J, Nam DH, Widhalm G, Sa JK, Woehrer A.: CLONAL ARCHITECTURE, TRANSCRIPTIONAL CELLULAR STATES AND IN-VITRO DRUG RESPONSE IN GLIOBLASTOMA. Neuro Oncol. 2023 Nov 10; 25(Suppl 5):v307. doi: 10.1093/neuonc/noad179.1191. IF: 15.9
• Mayr L, Trissal M, Schwark K, Neyazi S, Beck A, Labelle J, Marques JG, Weiler-Wichtl L, Madlener S, Kong S, Miclea M, Supko J, Guntner AS, Palova H, Neradil J, Stepien N, Loetsch-Gojo D, Dorfer C, Dieckmann K, Peyrl A, Azizi AA, Baumgartner AC, Slaby O, Pokorna P, Dubois F, Greenwald N, Bandopadhayay P, Beroukhim R, Ligon K, Kramm C, Bronsema A, Bailey S, Stuecklin AG, Mueller S, Skrypek M, Martinez N, Bowers DC, Jones D, Jones C, Jaeger N, Sterba J, Müllauer L, Haberler C, Kumar-Sinha C, Chinnaiyan A, Mody R, Furtner-Srajer J, Koschmann C, Gojo J, Filbin M.: CLINICAL RESPONSE TO THE PDGFRA/KIT INHIBITOR AVAPRITINIB IN PEDIATRIC AND YOUNG ADULT HIGH-GRADE GLIOMA PATIENTS. Neuro Oncol. 2023 Nov 10; 25(Suppl 5):v108–9. doi: 10.1093/neuonc/noad179.0411. IF: 15.9
• Greutter L, Miller-Michlits Y, Schnitzenlehner L,Klotz S, Krause E, Platzek S, Kiesel B, Widhalm G, Stepper P, Nenning K.-H., Langs G, Baumann B, Woehrer A.: AMYLOID-BETA AND TAU-PATHOLOGY IN THE GLIOMA VICINITY. Neuro-Oncology. 2023 Nov; 25, (Suppl5):v210, doi: https://doi.org/10.1093/neuonc/noad179.0799. IF: 15.9
• Gruber VE, Schachenhofer J, Fehrer SV, Haider C, Glatter S, Liszewska E, Höftberger R, Aronica E, Rössler K, Jaworski J, Scholl T, Feucht M.: The EGFR pathway as novel target for difficult to treat TSC. Epilepsia. 2023 Nov 1; 64:505-505 doi: 10.1111/nan.12974. IF: 5.6
• Mayer F, Diehm R, Glatter SE, Pimpel B, Vass M, Zielke JA, Tomschik M, Rössler K, Feucht M.: Localizing and prognostic value of pre-surgical interictal epileptiform discharges in pediatric patients with ganglioglioma related epilepsy - a pilot study. Epilepsia. 2023 Nov 29; doi: https://doi.org/10.1111/epi.17787. IF:5.6
• Tomschik M, Horner EM, Moser KM, Diehm R, Herta J, Czech T, Rössler K, Pataraia E, Feucht M, Dorfer C.: Clinical and histopathological factors influencing seizure outcome after ganglioglioma surgery. Epilepsia. 2023 Nov 29; doi: https://doi.org/10.1111/epi.17787. IF: 5.6
• Venturino A, Cubero RJA, Benevento M, Alamalhoda M, Schulz R, Rössler K, Czech T, Colombo G, Yeung J, Tasic B, Siegert S.: A sexual dimorphic microglia response modulates visual cortex network activity after ketamine-anesthesia. GLIA. 2023 Jul 1; 71:E1002. IF: 6.2
• Rössler K, Wais J, Tomschik M, Moser K, Mayer F, Kaprian G, Haberler C, Traub-Weidinger T, Dorfer C, Feucht M.: Towards better definition of a resection strategy in pediatric LEATs causing refractory epilepsy. Epilepsia. 2023 Nov 29; doi: https://doi.org/10.1111/epi.17787. IF: 5.6
• Rössler K, Tomschik M, Kasprian GJ, Hangel GJ, Wais J, Winter F, Mayer F, Moser KM, Feucht M, Dorfer C.: Advantages of laser induced thermal therapy (LITT) in children suffering from refractory epilepsy using a 3T intraoperative MRI suite. Epilepsia. 2023 Nov 29; doi: https://doi.org/10.1111/epi.17787. IF: 5.6
• Rössler K, Kasprian G, Chambers S, Haider L, Lazen P, Koren J, Diehm R, Moser K, Tomschik M, Wais J, Winter F, Gruber S, Aull-Watschinger S, Traub-Weidinger T, Baumgartner C, Feucht M, Pataraia E, Bogner W, Dorfer C, Trattnig S, Hangel GJ.: Does 7 Tesla epilepsy imaging improve diagnostic findings in daily practice? Epilepsia. 2023 Nov 29; doi: https://doi.org/10.1111/epi.17787. IF: 5.6
• Krajnc N, Macher S, Marik W, Michl M, Novak K, Wöber C, Pemp B, Bsteh G.: Treatment with anti-CGRP monoclonal antibodies in patients with idiopathic intracranial hypertension: a pilot study. European Journal of Neurology. 2023. IF: 5.1
• Krajnc N, Macher S, Marik W, Michl M, Novak K, Wöber C, Pemp B, Bsteh G.: Patients with Suspected Idiopathic Intracranial Hypertension: Is there a Reliable Score to Predict the Opening Pressure? European Journal of Neurology. 2023.  IF: 5.1
• Shi H, Metzelder M,^, Prayer F, Weber M, Kienast P, Khalaveh F, Nasel C, Binder Julia, Dovjak G, Stuempflen M, Prayer D, Kasprian G.: Multiparametric MR phenotyping of fetal brain edema in Chiari II malformation: opening novel ways to optimize outcomes of fetal surgery? IF: n.V.